How Roche fought to keep Avastin on the market for breast cancer, even though it does not increase cure nor length of survival
- Later studies found only a one- to three-month delay in breast cancer growth. And no studies showed Avastin extended the lives of patients with advanced breast cancer. Public release…
You must be logged in to post a comment.